Melflufen
CAS No. 380449-51-4
Melflufen ( Melphalan flufenamide;J1 )
Catalog No. M14311 CAS No. 380449-51-4
Melflufen is a novel dipeptide and alkylating prodrug of melphalan, inhibits angiogenesis in vitro and in vivo; shows cytotoxic activity against lymphoma cell lines with IC50 of 0.011-0.92 uM, also shows significantly lower IC50 than melphalan in multiple myeloma cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 873 | Get Quote |
|
50MG | 1782 | Get Quote |
|
100MG | 2250 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMelflufen
-
NoteResearch use only, not for human use.
-
Brief DescriptionMelflufen is a novel dipeptide and alkylating prodrug of melphalan, inhibits angiogenesis in vitro and in vivo; shows cytotoxic activity against lymphoma cell lines with IC50 of 0.011-0.92 uM, also shows significantly lower IC50 than melphalan in multiple myeloma cells.
-
DescriptionMelflufen (Melphalan flufenamide, J1)is a novel dipeptide and alkylating prodrug of melphalan, inhibits angiogenesis in vitro and in vivo; shows cytotoxic activity against lymphoma cell lines with IC50 of 0.011-0.92 uM, also shows significantly lower IC50 than melphalan in multiple myeloma cells; induces apoptosis even in melphalan- and bortezomib-resistant multiple myeloma cells.Blood Cancer Phase 3 Clinical
-
SynonymsMelphalan flufenamide;J1
-
PathwayCell Cycle/DNA Damage
-
TargetDNA Alkylator
-
RecptorDNA Alkylator
-
Research AreaCancer
-
IndicationBlood cancer
Chemical Information
-
CAS Number380449-51-4
-
Formula Weight498.42
-
Molecular FormulaC24H30Cl2FN3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCOC(=O)C(CC1=CC=C(C=C1)F)NC(=O)C(CC2=CC=C(C=C2)N(CCCl)CCCl)N
-
Chemical Nameethyl (S)-2-((S)-2-amino-3-(4-(bis(2-chloroethyl)amino)phenyl)propanamido)-3-(4-fluorophenyl)propanoate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wickstrm M, et al. Oncotarget. 2017 Jun 8;8(39):66641-66655.
2. Carlier C, et al. Oncotarget. 2016 Sep 13;7(37):59322-59335.
3. Delforoush M, et al. BMC Cancer. 2016 Apr 4;16:263.
4. Chauhan D, et al. Clin Cancer Res. 2013 Jun 1;19(11):3019-31.
2. Carlier C, et al. Oncotarget. 2016 Sep 13;7(37):59322-59335.
3. Delforoush M, et al. BMC Cancer. 2016 Apr 4;16:263.
4. Chauhan D, et al. Clin Cancer Res. 2013 Jun 1;19(11):3019-31.
molnova catalog
related products
-
Satraplatin
Satraplatin (BMS-182751, BMY-45594, JM-216) is a platinum-based antineoplastic agent that binds to guanine residues in DNA, inhibits DNA replication and transcription, leads to subsequent apoptosis.
-
Duocarmycin TM
Duocarmycin TM is a DNA alkylator. Duocarmycin TM is an exceptionally potent antitumor antibiotic.
-
Alchemix
A dual action as an alkylating agent and topoisomerase inhibitor with potent activity against anthracycline- and cisplatin-resistant tumor cancer.